Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies

被引：45

作者：

Luong, Me-Linh ^{[1
,2
]}

Filion, Charles ^{[1
]}

Labbe, Annie-Claude ^{[1
]}

Roy, Jean ^{[3
]}

Pepin, Jacques ^{[4
]}

Cadrin-Tourigny, Julia ^{[1
]}

Carignan, Stephane ^{[5
]}

Sheppard, Donald C. ^{[2
]}

Laverdiere, Michel ^{[1
]}

机构：

[1] Univ Montreal, Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ H1T 2M4, Canada

[2] McGill Univ, Ctr Hlth, Dept Microbiol, Montreal, PQ H3A 2B4, Canada

[3] Univ Montreal, Hop Maison Neuve Rosemont, Dept Med, Div Hematooncol, Montreal, PQ H1T 2M4, Canada

[4] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada

[5] Univ Montreal, Hop Maison Neuve Rosemont, Dept Radiol, Montreal, PQ H1T 2M4, Canada

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2010年 / 68卷 / 02期

关键词：

Aspergillosis; Galactomannan; Bronchoalveolar lavage; Hematologic malignancies; INVASIVE PULMONARY ASPERGILLOSIS; CELL TRANSPLANT RECIPIENTS; ENZYME-IMMUNOASSAY; FUNGAL-INFECTIONS; ANTIGEN-DETECTION; MOLD INFECTIONS; DIAGNOSIS; FLUID; SERUM; ASSAY;

D O I：

10.1016/j.diagmicrobio.2010.03.017

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We conducted a single-center retrospective cohort study to determine the performance characteristics of the galactomannan (GM) assay in bronchoalveolar lavage (BAL) in patients with hematologic malignancies. Patients were classified as proven, probable, possible, or no invasive pulmonary aspergillosis (IPA), according to international guidelines. A total of 173 BAL samples from 145 patients were included. There were 5 proven, 7 probable, and 35 possible cases of IPA. Using a GM index cutoff of >= 0.5, the sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) of the BAL GM assay were 100%, 78%, 26%, and 100%, respectively. Using a GM index cutoff of >= 2.0, sensitivity and NPV remained 100%, but specificity and PPV increased to 93% and 50%, respectively. The BAL GM assay is a highly sensitive screening test for IPA in patients with hematologic malignancies. Increasing the cutoff value to 2.0 would improve the performance of this assay. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：132 / 139

页数：8

共 50 条

[1] Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies
Taremi, Mahnaz
Kleinberg, Michael E.
Wang, Elizabeth W.
Gilliam, Bruce L.
Ryscavage, Patrick A.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14
[2] Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients
Brownback, Kyle R.
Pitts, Lucas R.
Simpson, Steven Q.
MYCOSES, 2013, 56 (05) : 552 - 558
[3] Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies
Heng, Siow-Chin
Chen, Sharon C. -A.
Morrissey, C. Orla
Thursky, Karin
Manser, Renee L.
De Silva, Harini D.
Halliday, Catriona L.
Seymour, John F.
Nation, Roger L.
Kong, David C. M.
Slavin, Monica A.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 79 (03) : 322 - 327
[4] Galactomannan Testing in Bronchoalveolar Lavage Fluid Facilitates the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies and Stem Cell Transplant Recipients
Nguyen, M. Hong
Leather, Helen
Clancy, Cornelius J.
Cline, Christina
Jantz, Michael A.
Kulkami, Varsha
Wheat, L. Joseph
Wingard, John R.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 1043 - 1050
[5] Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies
Mahnaz Taremi
Michael E. Kleinberg
Elizabeth W. Wang
Bruce L. Gilliam
Patrick A. Ryscavage
Annals of Clinical Microbiology and Antimicrobials, 14
[6] Diagnosis of invasive pulmonary aspergillosis: Value of bronchoalveolar lavage galactomannan for immunocompromised patients
Paugam, A.
Baixench, M. -T.
Lebuisson, A.
Dupouy-Camet, J.
PATHOLOGIE BIOLOGIE, 2010, 58 (01): : 100 - 103
[7] Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis
Hadrich, I.
Makni, F.
Cheikhrouhou, F.
Neji, S.
Amouri, I.
Sellami, H.
Trabelsi, H.
Bellaaj, H.
Elloumi, M.
Ayadi, A.
PATHOLOGIE BIOLOGIE, 2012, 60 (06): : 357 - 361
[8] Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
Maertens, Johan
Maertens, Vincent
Theunissen, Koen
Meersseman, Wouter
Meersseman, Philippe
Meers, Stef
Verbeken, Eric
Verhoef, Gregor
Van Eldere, Johan
Lagrou, Katrien
CLINICAL INFECTIOUS DISEASES, 2009, 49 (11) : 1688 - 1693
[9] False positive bronchoalveolar lavage galactomannan: Effect of host and cut-off value
Farmakiotis, Dimitrios
Le, Audrey
Weiss, Zoe
Ismail, Nour
Kubiak, David W.
Koo, Sophia
MYCOSES, 2019, 62 (03) : 204 - 213
[10] Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
D'Haese, Jorien
Theunissen, Koen
Vermeulen, Edith
Schoemans, Helene
De Vlieger, Greet
Lammertijn, Liesbet
Meersseman, Philippe
Meersseman, Wouter
Lagrou, Katrien
Maertens, Johan
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (04) : 1258 - 1263

← 1 2 3 4 5 →